The impact of germline mutations on AML managment

preview_player
Показать описание
Lucy Godley, MD, PhD, University of Chicago, Chicago, IL, discusses how the distinction between somatic and germline mutations has a significant impact on the patient’s management as well as important implications for their family members. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Рекомендации по теме
welcome to shbcf.ru